MedTrace Logo

Study of the Immune Response to Hepatitis C Virus

NCT00237432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2010-12-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the mechanism of a successful immune response to hepatitis C virus (HCV) infection. Currently, it is believed that the immune system is involved in responding to HCV infection, but how it is involved is not known. It is estimated that 30% of individuals infected with HCV are able to clear the virus without treatment, while 70% progress to chronic infectious. By studying the immune responses in these two populations, we, the researchers at Rockefeller University, hope to gain insight into the mechanisms of the immune response and develop new strategies for HCV therapy.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Charles M. Rice, PHD · Rockefeller University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00237432 on ClinicalTrials.gov